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1  |  INTRODUC TION
Ageing is considered the primary risk factor for many devastating 
pathologies, including neurodegenerative diseases, which primar-
ily affect neurons. There is robust evidence, however, for non-cell 
autonomous mechanisms in which neurodegeneration is influenced 
or even driven by glial cells (Chai & Kohyama, 2019; Domenico et al., 
2019; Lee et al., 2016; Lobsiger & Cleveland, 2007; Meyer et al., 2014).
Astrocytes, the most abundant non-neuronal cell population in the 
central nervous system (CNS), are known to guide brain development 
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Abstract
Astrocytes are highly specialised cells, responsible for CNS homeostasis and neuronal 
activity. Lack of human in vitro systems able to recapitulate the functional changes 
affecting astrocytes during ageing represents a major limitation to studying mech-
anisms and potential therapies aiming to preserve neuronal health. Here, we show 
that induced astrocytes from fibroblasts donors in their childhood or adulthood dis-
play age-related transcriptional differences and functionally diverge in a spectrum of 
age-associated features, such as altered nuclear compartmentalisation, nucleocyto-
plasmic shuttling properties, oxidative stress response and DNA damage response. 
Remarkably, we also show an age-related differential response of induced neural 
progenitor cells derived astrocytes (iNPC-As) in their ability to support neurons in 
co-culture upon pro-inflammatory stimuli. These results show that iNPC-As are a re-
newable, readily available resource of human glia that retain the age-related features 
of the donor fibroblasts, making them a unique and valuable model to interrogate 
human astrocyte function over time in human CNS health and disease.
K E Y W O R D S
ageing, astrocytes, direct reprogramming, in vitro model, neurodegeneration, 
neuroinflammation, neuron-astrocyte crosstalk, nuclear abnormalities, nucleocytoplasmic 
transport, oxidative stress
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(Verkhratsky & Nedergaard, 2016) and to play a crucial role in CNS 
homeostasis and repair (Parpura et al., 2012). Moreover, studies in-
terrogating the gene expression profile of rodent and humans neu-
rons, astrocytes and microglia have found that astrocytes, more than 
neurons, dramatically change their gene expression pattern with age 
(Soreq et al., 2017). This indicates that they might be significant driv-
ers of the ageing process and preservation of their physiological func-
tions over time will clearly support neuronal health.
Changes in glial functions, such as reduced redox homeostasis and 
increased pro-inflammatory responses, are hallmarks of the ageing brain 
(Bellaver et al., 2017; Lynch et al., 2010; Matias et al., 2019). Consistently, 
in vitro studies comparing primary astrocytes from young and old ro-
dents have shown changes in the expression of the nuclear factor eryth-
roid-derived 2-like 2 (Nrf2) (Duan et al., 2009; Lewis et al., 2015) and 
nuclear factor kappa B (NFκB)	(Osorio	et	al.,	2016;	Tilstra	et	al.,	2011),	
master regulators of the antioxidant and inflammatory response respec-
tively. A decrease in the effectiveness of the antioxidant response in the 
ageing brain leads to accumulation of oxidised nucleic acids, proteins and 
lipids (Gemma et al., 2007), while increased NFκB activity exacerbates 
the production of pro-inflammatory cytokines (Lynch, 2010; Rea et al., 
2018). Both processes are known to participate in neurodegeneration 
and are therefore considered appealing therapeutic targets.
The lack of human in vitro models that recapitulate the functional 
changes affecting astrocytes throughout ageing represents a major lim-
itation for studying relevant mechanisms and potential therapies aiming 
to preserve brain health, as well as targeting age-related neurodegener-
ative disorders. Studies using astrocytes isolated from postmortem (PM) 
human samples (Blasko et al., 2000; Re et al., 2014) have shed light on 
important disease mechanisms, but the availability of these cells is lim-
ited and their function might be altered by factors related to post-mor-
tem collection, hence the need for widely available, reproducible human 
in vitro models that retain age-related biochemical alterations.
So far, somatic cell reprogramming is the most commonly used 
methodology (Takahashi et al., 2007) to address the challenges of 
modelling human neurodegenerative diseases. The induction of plu-
ripotency factors in adult fibroblasts, however, reverts cellular age 
to an embryonic status (Lapasset et al., 2011; Patterson et al., 2012), 
which is retained even after conversion into neurons, erasing age-
ing-associated signatures (Miller et al., 2013). To circumvent this limita-
tion, recent studies have shown that neurons directly reprogrammed 
from fibroblasts without the use of pluripotency factors retain ageing 
signatures compared to induced pluripotent stem cells (iPSC)-derived 
neurons (Huh et al., 2016; Mertens et al., 2015; Tang et al., 2017; Victor 
et al., 2018). Direct conversion preserves ageing features in neurons; 
however, no study has yet achieved this goal in astrocytes. Most 
available protocols for derivation of human astrocytes utilise iPSCs 
are time-consuming and have low conversion efficiency (Almad & 
Maragakis, 2018). Although recent methodologies have made human 
astrocyte production from iPSCs faster (Canals et al., 2018; Tchieu 
et al., 2019), the field is still lacking an in vitro human astrocyte system 
able to retain the ageing characteristics of the donor.
In	 2014,	 we	 described	 the	 first	 human-derived	 astrocytes	 dif-
ferentiated from tripotent-induced neural progenitor cells (iNPCs) 
directly converted from adult fibroblasts (Meyer et al., 2014). This pro-
tocol is fast and highly efficient and does not involve clonal expansion, 
thus greatly reducing the variability associated with iPSCs (Mertens 
et	al.,	2018;	Ortmann	&	Vallier,	2017).	Induced	NPCs	can	be	expanded	
and stored for several passages and are an immediate source of neu-
rons (Webster et al., 2016), oligodendrocytes (Ferraiuolo et al., 2016) 
and	 astrocytes.	 Induced-NPC	 derived	 astrocytes	 (iNPC-As)	 can	 be	
obtained from iNPCs in only 7 days and have been utilised to study 
childhood (Boczonadi et al., 2018) and adult-onset neurodegenerative 
disorders, including amyotrophic lateral sclerosis (ALS) (Hautbergue 
et al., 2017; Meyer et al., 2014; Varcianna et al., 2019).
The ability of this protocol to retain ageing features at transcrip-
tional and functional level had not been interrogated before.
In	the	present	study,	we	assess	the	ability	of	this	direct	conversion	
methodology to retain the ageing features of the donor's fibroblasts. 
Comparing the gene expression profiles of iNPC-As derived from donors 
in childhood or adulthood with transcriptomic data from adult post-mor-
tem (PM) and foetal astrocytes revealed that iNPC-As reproduce tran-
scriptional age-related features. We then showed how iNPC-As from 
the two different age groups diverge in relation to a spectrum of age-as-
sociated features, such as accumulation of DNA damage, altered nuclear 
compartmentalisation, oxidative stress and nucleocytoplasmic shuttling 
defects. Furthermore, we showed an age-related differential response 
of iNPC-As in their ability to support neurons in co-culture upon stimu-
lation	with	the	inflammatory	cytokine	interleukin-1	beta	(IL-1β).
In	conclusion,	our	results	show	that	age-related	features	are	re-
tained in iNPC-As reprogrammed from donor fibroblasts, thus mak-
ing this model a reliable and accessible tool to interrogate human 
astrocyte function over the life course in health and disease.
2  |  RESULTS
2.1  |  Efficient differentiation of iNPC-As from 
young and old donor fibroblasts
To determine whether astrocytes derived from iNPCs directly 
converted from fibroblasts (Meyer et al., 2014) retain the age-
ing features of the donor, we set out to directly reprogramme 
F I G U R E  1 Characterisation	of	iNPC-As	from	old	versus	young	donors.	(a)	Schematic	illustration	of	the	differentiation	protocol,	from	
young and old donor fibroblasts to induced neuronal progenitor cell derived astrocytes (iNPC-As). (b) Representative images of PAX6/Nestin 
staining in young and old donor-derived iNPCs. Scale bar (10 µm). See also Figure S1 for markers quantification. (c) Representative images 
of	astrocytic	markers	(GFAP,	vimentin	(VIM),	CD44	and	EAAT2)	in	young	and	old	donor-derived	iNPC-As,	Scale	bar	(10	µm).	See	also	Figure	
S1 for markers quantification. (d) Quantitative image analysis of cell area (µm2) in young and old donor-derived iNPC-As was assessed using 
Columbus	Software.	Unpaired	t test, *p < 0.05 (n = 3/group). (e) GFAP and vimentin (f) intensity quantification in young and old donor-
derived	iNPC-As	was	assessed	using	Columbus	Software.	Unpaired	t	test,	**p < 0.01, ***p < 0.001 (n = 3/group)
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fibroblasts from individuals belonging to two distinct age groups. 
Fibroblast samples from three donors ranging in age from 42 to 
56 years and three donors ranging in age from 5 months to 3 years 
(Table S1) were directly reprogrammed to iNPCs (Figure 1a), which 
stained positive for the neural progenitor markers Pax6 and Nestin 
(Figure 1b). Passage matched old and young donor-derived iNPCs 
were then differentiated into iNPC-As in 7 days as previously de-
scribed (Meyer et al., 2014). iNPC-As from both young and old 
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donors expressed typical astrocytic markers, including glial fibril-
lary	acidic	protein	(GFAP),	vimentin	(VIM),	CD44	and	the	glutamate	
transporter EAAT2, a marker of mature astrocytes (Figure 1c). This 
protocol is highly efficient, yielding >98% iNPCs positive for Pax6 
and Nestin (Figure S1A,B) and >98% iNPC-As positive for GFAP, 
VIM,	CD44	and	EAAT2	(Figure	S1C-F).	Interestingly,	iNPC-As	de-
rived from different donors are morphologically heterogeneous 
one from the other, but display consistent individual morphologi-
cal characteristics, which are retained throughout different differ-
entiation rounds starting from iNPCs. As noticeable in Figure 1c, 
astrocytes derived from old donors consistently display a larger 
cell morphology (Figure 1d), suggesting that older iNPC-As might 
be hypertrophic and mildly reactive at baseline, as indicated by 
the increased expression of GFAP and vimentin (Figure 1e,f). This 
phenotype has been previously reported in physiologically ageing 
brains (Sofroniew & Vinters, 2010).
2.2  |  Transcription profile discriminates iNPC-As 
from young and old donors and segregates them 
according to age-related gene expression signatures
To interrogate the transcriptional features of fibroblast-derived 
iNPC-As in relation to their ageing phenotype, we compared tran-
scriptomic data from iNPC-As obtained from old and young donors 
to bona fide human astrocytes laser captured from postmortem 
F I G U R E  2 Old	donor	iNPC-As	and	postmortem	(PM)	astrocytes	have	distinctly	different	transcriptomes	to	foetal	astrocytes	and	young	
donor iNPC-As. (a) Principal component analysis (PCA) plot of foetal astrocytes, PM astrocytes and old and young donor-derived iNPC-
As. Multigroup comparison, p	≤	1	×	10e-4.	(b)	Hierarchical	cluster	heat-map	of	foetal	astrocytes,	PM	astrocytes	and	old	and	young	donor	
iNPC-As. Multigroup comparison, p	≤	1	×	10e-4.	(c)	Venn	diagram	representing	two-group	comparison	analysis	(p-value	≤.05;	fold	change	
>1.5) between PM and foetal astrocytes as well as iNPC-As from young and old donors. PM versus foetal astrocytes comparison reported 
7875	differentially	expressed	transcripts,	while	young	and	old	donors	iNPC-As	reported	1639.	One	thousand	two	hundred	and	ninety	eight	
differentially expressed transcripts were common to both comparisons. Approximately 80% of the transcriptional differences between 
young and old iNPC-As matched the corresponding comparison between PM and foetal primary human astrocytes. See also Figure S2 and 
Table S3
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(PM) brains (Simpson et al., 2011; Waller et al., 2012) and foetal 
primary astrocytes (Table S2). After signal normalisation and har-
monisation of the four datasets, gene expression levels of 18,357 
transcripts were imported into the bioinformatics software 
Qlucore. The data were then visualised using a principal compo-
nent analysis (PCA) plot (Figure 2a), with application of stringent 
multigroup comparison statistics (p-value	≤1	×	10e-4).	This	analy-
sis identified 16,284 differentially expressed transcripts that de-
termined	sample	grouping	on	the	PCA	plot	(Figure	2a).	Using	the	
same parameters, we also visualised the sample groups based on 
transcript levels in a hierarchical cluster heat map (Figure 2b). Both 
data representation plots showed that iNPC-As from the two dif-
ferent age groups have distinct transcription profiles, which group 
closely with their bona fide	 astrocyte	 counterpart.	 In	 fact,	 indi-
viduals in their 5th-6th decade of life (old donor) group closely 
with astrocytes taken at PM from older individuals, while iNPC-
As from individuals in their 1st decade of life (young donor), al-
though clearly separate from foetal astrocytes, group more closely 
to	 these	samples.	 In	order	 to	determine	whether	 the	 transcripts	
described age-related features, we downloaded a human dataset 
of 307 genes commonly altered during ageing, from the Human 
Genomic Resources (HAGR), GenAge database (https://genom 
ics.senes cence.info/genes/ index.html). From this list of 307 
genes, 285 genes were present in the list of 16,284 transcripts 
that determined the sample subgrouping. Consistently, the PCA 
plot (Figure S2A) and the hierarchical clustering (Figure S2B) of 
the four groups in relation to these 285 age-related transcripts 
confirmed the separation between PM and foetal astrocytes and 
iNPC-As in the two age groups (Figure S2). We also performed 
two-group comparison analysis (p-value	≤0.05,	fold	change	>1.5),	
between bona fide astrocytes from different age groups, PM and 
foetal astrocytes, as well as iNPC-As from young and old donors. 
The first comparison (PM vs. foetal astrocytes) reported 7875 
differentially expressed transcripts, with only eight transcripts 
overexpressed in PM astrocytes compared to foetal. The second 
comparison (young vs. old iNPC-As) reported 1639 with only five 
transcripts overexpressed in old iNPC-As in comparison with the 
young. We then proceeded to interrogate how many of these dif-
ferentially expressed transcripts were common to both compari-
sons, and almost 80% of the transcriptional differences between 
young and old iNPC-As, that is, 1298 transcripts, matched the cor-
responding comparison between PM and foetal primary human 
astrocytes (Figure 2c) with only two transcripts overexpressed in 
the old astrocytes compared to young. Pathway analysis of these 
1298 transcripts (Table S3) via Panther (http://www.panth erdb.
org/) identified several physiological and pathological processes 
known to be associated with ageing (Table 1).
This skew towards transcript downregulation was absent when 
comparing	astrocyte	groups	of	the	same	age.	Only	244	transcripts	
were dysregulated when comparing PM versus old iNPC-As (142 up 
and 102 downregulated), while 1138 transcripts were dysregulated 
when comparing foetal versus young iNPC-As, with 972 upregulated 
and 166 downregulated transcripts in foetal astrocytes. Although 
this is a preliminary observation, this trend might indicate a progres-
sive suppression of transcription throughout development and age-
ing (Stegeman & Weake, 2017).
2.3  |  iNPC-As from older donors recapitulate 
nuclear ageing features
In	order	to	determine	whether	the	expression	of	specific	age-asso-
ciated transcripts was preserved between iNPC-As and their fibro-
blasts of origin, we interrogated the expression of three transcripts 
that have been previously identified as consistently decreasing with 
ageing in various tissues (Godin et al., 2016; Martínez et al., 2014; 
Mertens et al., 2015). RAN binding protein 17 (RANBP17) and laminin 
subunit alpha 3A (LAMA3A) were identified by Mertens et al when 
comparing the transcriptomes of human fibroblasts and brain sam-
ples from a broad range of aged donors. Their change in expression 
was shown to be maintained between fibroblasts and derived di-
rectly reprogrammed neurons (iNeurons), but not iPSC-derived neu-
rons. RANBP17 is a nuclear pore-associated transport receptor, a 
TA B L E  1 Table	illustrating	the	pathways	identified	by	the	1298	
transcripts intersecting the comparisons between PM versus foetal 
astrocytes as well as iNPC-As from young versus old donors.
Pathway name
% 
transcripts
Integrin	signalling	pathway 4.50
Wnt signalling pathway 4.20
Huntington disease 3.40
Inflammation	mediated	by	chemokine	and	cytokine	
signalling pathway
3.40
EGF receptor signalling pathway 3.20
DNA damage signalling pathway 2.20
Alzheimer disease-amyloid secretase and presenilin 
pathway
2
Cytoskeletal regulation by Rho GTPase 1.90
Parkinson disease 1.90
p53 pathway 1.80
Ubiquitin	proteasome	pathway 1.80
TGF-beta signalling pathway 1.60
Oxidative	stress	response 1.60
Heterotrimeric G protein signalling pathway-Gi alpha 
and Gs alpha mediated pathway
1.50
Axon guidance mediated by semaphorins 1.40
PI3	kinase	pathway 1.30
VEGF signalling pathway 1.30
Glutamate receptor pathway 1
Insulin/IGF	pathway	mitogen-activated	protein	
kinase kinase/MAP kinase cascade
0.90
Protein biosynthesis 0.70
p38 MAPK pathway 0.60
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member of the importin-β family, involved in the transport of nuclear 
localisation signal (NLS)-containing cargo proteins through the nu-
clear pore complex (NuPC) (Koch et al., 2000; Lee et al., 2010), while 
LAMA3, also reported to decrease with age in other in vivo studies 
(Godin	et	al.,	2016),	encodes	an	extracellular	matrix	protein.	In	ad-
dition, we also assessed the expression of telomeric repeat-binding 
factor 2 (TERF2), a component of shelterin that together with TERF1 
is responsible for telomerase maintenance (Martínez et al., 2014), 
and	telomere	 length	 (Smogorzewska	et	al.,	2000).	 It	 is	well	known	
that telomerase activity is crucial in determining telomere length in 
ageing cells and that telomere length can be considered as a bio-
marker of chronological ageing (Fasching, 2018; Rizvi et al., 2015). 
In	 agreement	with	 previous	 reports,	 our	 results	 show	 that	TERF2, 
RANBP17 and LAMA3 mRNA levels decrease significantly with age 
in fibroblasts and we show here that iNPC-As retain this decline in 
expression levels after reprogramming (Figure 3a-c). Consistent with 
the age-related decline in TERF2, qPCR data of genomic DNA show 
a significant difference between telomere length in young and old 
iNPC-As (Figure 3d). As a control, we also assessed telomere length 
in iPSCs derived from a different set of fibroblast donors 1 month 
and 55 years of age, and, as expected, we found no difference in 
their telomere length regardless of donor's age.
In	addition	 to	assessment	of	 transcriptional	 features,	we	 inter-
rogated cellular parameters that have previously been reported to 
change with age, including nuclear size and shape (Haithcock et al., 
2005; Pienta et al., 1992), as well as histone methylation (Miller et al., 
2013).
It	 is	well	documented	how	nuclear	structure	 is	affected	during	
ageing (Haithcock et al., 2005; Scaffidi et al., 2005). Heterochromatin 
organisation and nuclear shape were assessed via immunostaining 
using the heterochromatin-associated trimethylated ‘Lys-9’ on his-
tone H3 marker (H3K9me3) and the nuclear lamina marker lamin 
A/C. H3K9me3 is the hallmark of constitutive heterochromatin 
(Maleszewska et al., 2016), while Lamin A/C coded by the gene 
LMNA, is part of the lamin protein family, which form components of 
the nuclear lamina (Liu & Zhou, 2008).
Consistent with previous reports describing an overall decrease 
in H3K9me3 in cells and tissues (Miller et al., 2013) iNPC-As from 
older donors displayed a significant global reduction of H3K9me3 
staining	(Figure	3f,i).	Immunostaining	of	lamin	A/C	also	confirmed	
that iNPC-As from older donors displayed significant nuclear 
morphology alterations, with increased nuclear folding and bleb-
bing. Lamin staining is clearly localised in the nuclear membrane 
and defines nuclear shape in young iNPC-As, while it displays frag-
mented and less spherical staining in iNPC-As from older donors 
(Figure	3g,j).	In	addition,	we	report	a	significant	increase	in	nuclear	
size assessed by Hoechst staining in old iNPC-As (Figure 3e,h). 
Similar findings have been reported in in vitro and in vivo fibro-
blasts (Mukherjee & Weinstein, 1986; Pienta et al., 1992).
Taken together, these results demonstrate that iNPC-As repro-
grammed from donors of different age groups retain some of the 
ageing features of their parental fibroblasts and exhibit well-de-
scribed ageing morphological characteristics.
2.4  |  iNPC-As reveal age-related nuclear 
permeability and nucleocytoplasmic transport defects
In	order	to	examine	further	the	nuclear	envelope	abnormalities	de-
tected via lamin A/C staining, we set out to interrogate the overall 
integrity of another nuclear component, the nuclear pore complex 
(NucPC). Seminal work (D’Angelo et al., 2009) has previously re-
vealed that the NucPC is highly affected by age in post-mitotic cells, 
leading to nuclear ‘leakiness’. This phenomenon has also been re-
cently highlighted as critically important in age-related diseases, 
such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease 
(AD) (Eftekharzadeh et al., 2018; Kim & Taylor, 2017).
In	 intact	 nuclei,	 molecules	 of	 up	 to	 40–50	 kDa	 can	 pass	
through the NucPC via passive diffusion, while molecules larger 
than 60 kDa are excluded from intact nuclei (Lénárt & Ellenberg, 
2006). Thus, we analysed the overall nuclear permeability in 
young and old donor iNPC-As, by isolating nuclei from both groups 
of iNPC-As and incubating them with a 70 kDa fluorescently la-
belled dextran (Figure 4a). Nuclei were then stained for Hoescht 
and imaged using a confocal microscope. We found that influx of 
the 70 kDa dextran was observed only in the old donor-derived 
iNPC-A nuclei (Figure 4b), and not in young donor-derived iNPC-A 
nuclei. This confirms that direct conversion of fibroblasts into 
iNPCs and subsequently iNPC-As retains a key characteristic of 
ageing that is often associated with neurodegenerative conditions 
(D’Angelo et al., 2009) and so far has been primarily associated 
with neuronal ageing.
F I G U R E  3 Young	and	old	iNPC-As	retain	the	ageing	phenotype	of	their	fibroblasts	of	origin.	(a)	Quantification	of	RANBP17, LAMA3A (b) 
and TERF2 (c) mRNA levels in young and old donor fibroblasts and derived iNPC-As Three old and three young iNPC-As lines were assessed 
(n	=	3	biological	replicates/group	and	each	line	was	assessed	three	times).	Error	bars	=	SD;	Unpaired	t test. (d) Telomere length of iPSC cells 
and iNPC-derived astrocytes from young and old donors using the Absolute Human Telomere Length quantification qPCR assay Kit. Three 
old and three young iNPC-As lines were assessed (n	=	3	biological	replicates/group).	Error	bars	=	SD	Unpaired	t test. (e) Representative 
images of Hoechst, H3K9me3 (f), Lamin A/C (g) staining in young and old donor-derived iNPC-As. Scale bar (10 µm). (h) Quantitative image 
analysis of nuclear sizes(µm2), H3K9me3 intensity (i) in young versus old donor-derived iNPC-As. Nuclear size was assessed using Columbus 
Software.	Error	bars	=	SD	Unpaired	t test, **p < 0.01, ****p < 0.0001. Mean values per well from three old and three young iNPC-As lines 
were assessed (n = 3 biological replicates/group); each experiment included three technical repeats and in each well between 500 and 700 
cells were assessed. (j) Lamin A/C nuclear envelope roundness. Values from a total of about 3600 cells assessed in each age group, that 
is, three old and three young iNPC-As lines (about 1200 cells per line) are plotted to assess the distribution of cell roundness phenotypes. 
Unpaired	t test
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Further, we assessed the levels of three proteins involved in 
active	 nucleocytoplasmic	 transport,	 that	 is,	 RANBP17,	 Importin	 5	
(IPO5)	and	Exportin	1	(XPO1).	IPO5	is	a	member	of	the	importin-β 
family of nuclear transport receptors that mediates transport of pro-
teins carrying a nuclear localisation signal (NLS), RANBP17 serves 
as	 nuclear	 import	 receptor,	 while	 XPO1	mediates	 the	 nuclear	 ex-
port of cellular proteins bearing a leucine-rich nuclear export signal 
(NES) and of some non-coding RNA molecules including snRNAs and 
rRNAs.
Consistent with reports that nucleocytoplasmic transport be-
comes impaired with age and in neurodegeneration (Ferreira, 2019; 
Hutten & Dormann, 2019; Kim & Taylor, 2017; Ribezzo et al., 2016), 
our	results	show	that	RANBP17,	IPO5	and	XPO1	protein	levels	are	
significantly decreased in older compared to young donor-derived 
iNPC-As	(Figure	4c–f).
2.5  |  Older donor-derived iNPC-As display lower 
antioxidant defences
A key hallmark of ageing is rising levels of oxidative stress and ac-
cumulation	of	reactive	oxygen	species	(ROS)	that	leads	to	nucleic	
acid, protein and lipid oxidation. Astrocytes are the principal cell 
type in the CNS responsible for counteracting the increase in oxi-
dative stress through the antioxidant response and noncell auton-
omous support of neurons (Bell et al., 2011). To test the hypothesis 
that reprogrammed iNPC-As from donors of different ages can 
model this central aspect of astrocyte function, we quantified the 
endogenous	levels	of	ROS	in	iNPC-As	from	naïve	young	and	old	do-
nors,	using	the	CellROX®	Oxidative	Stress	Reagent,	a	fluorogenic	
probe	designed	to	measure	ROS	in	 live	cells.	We	found	that	ROS	
levels were significantly higher in old compared to young donor-
derived iNPC-As under basal conditions (Figure 5a,b). To test how 
iNPC-As respond to stressors that increase oxidative stress over 
time, we also performed a time-course experiment. We measured 
intracellular	levels	of	ROS	in	young	and	old	donor	iNPC-As	at	base-
line before subjecting the cells to 12 h of serum starvation. After 
12	h,	we	measured	the	 levels	of	 intracellular	ROS	in	both	groups	
of iNPC-As, and then following a change to full iNPC-A medium 
assessed how long it took the cells to return to baseline levels of 
ROS.	Our	measurements	show	that	both	young	and	old	donor-de-
rived	iNPC-As	display	an	increase	in	intracellular	ROS	after	serum	
starvation and recover after removing the stimulus, going back 
to baseline levels (Figure 5c). Remarkably, iNPC-As from younger 
individuals recovered to their baseline levels after only 4 h, while 
iNPC-As from older individuals required a longer time-period of 
6 h (Figure 5c).
To understand what changes may underlie the increased 
levels	of	ROS	 seen	 in	old	 iNPC-As	at	baseline,	 and	 the	delayed	
recovery from oxidative stress following serum starvation, we 
investigated the levels of NRF2, the master regulator of antiox-
idant	defences,	and	superoxide	dismutase	1	(SOD1),	a	major	an-
tioxidant enzyme responsible for the breakdown of superoxide 
radicals. Both NRF2 and SOD1 are present on the list of ageing 
genes that are downregulated in both PM and old iNPC-As versus 
foetal astrocytes and young iNPC-As in our microarray analysis 
(Figure 2 and Figure S2B). Consistent with in vivo data (Paladino 
et al., 2018) and our transcriptomic data, we found that NRF2 and 
SOD1	 baseline	 levels	 are	 significantly	 lower	 in	 old	 as	 opposed	
to	young	donor-derived	iNPC-As	(Figure	5d–f).	The	lowered	an-
tioxidant defences present in old iNPC-As may explain the in-
creased	 levels	 of	 baseline	 ROS	 species	 observed	 (Figure	 5a,b).	
Considering the ability of both young and old donor iNPC-As to 
respond to the oxidative stress generated by serum starvation 
treatment (Figure 5c), we set out to evaluate the protein levels 
of	NRF2	and	SOD1	in	response	to	this	stressor.	As	suggested	by	
our time-course experiments (Figure 5c), we observed a signif-
icant increase in NRF2 protein level in iNPC-As from both age 
groups, thus showing that both groups can respond to acute 
oxidative stress insults. However, the total levels of NRF2 and 
SOD1	were	still	 lower	in	old	compared	to	young	iNPC-As	in	the	
serum-starved conditions, giving a potential explanation for the 
decreased and slower response to counteract oxidative stress 
after	the	insult	(Figure	5d–f).
Oxidative	stress	 is	known	to	affect	cell	 function	 in	many	ways	
through	protein,	lipid	and	nucleic	acid	oxidation.	In	particular,	DNA	
damage has been recognised as a causal factor in the ageing process 
and its markers are hallmarks of aged tissues, especially in the CNS, 
where cell turnover is limited (Lu et al., 2004). The current hypoth-
esis is that DNA damage accumulation with ageing causes loss of 
key cellular functions leading to degeneration (Ribezzo et al., 2016). 
In	 order	 to	 repair	 these	 lesions,	 in	 particular	 DNA	 double-strand	
breaks (DSBs), the DNA damage response (DDR) starts at the dam-
age site with the phosphorylation of the C-terminal of the core 
histone protein H2AX (γH2AX). Consistent with the increase in 
ROS	and	concomitant	decrease	in	the	antioxidant	response,	we	de-
tected an increase in γH2AX foci in old compared to young iNPC-As 
(Figure 5g,h).
F I G U R E  4 Old	and	young	iNPC-As	show	differential	nuclear	permeability	and	nucleocytoplasmic	shuttling/export	protein	amounts.	(a)	
Schematic	illustration	of	the	nuclear	isolation	protocol	for	dextran	application.	(b)	Representative	images	of	TRITC-labelled	dextran	influx	
in	young	versus	old	donor-derived	iNPC-As.	(c)	Representative	images	of	western	blot	analysis	of	RANBP17,	IPO5	and	XPO1.	Protein	
from young and old donor-derived iNPC-As was separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis followed by 
immunoblotting.	(d)	Densitometric	quantification	of	RANBP17	normalised	to	GAPDH.	Unpaired	t test, **p < 0.01 (n = 3). (e) Densitometric 
quantification	of	XPO1	normalised	to	GAPDH.	Unpaired	t test, *p < 0.05. (n	=	3).	(f)	Densitometric	quantification	of	IPO5	normalised	
to	GAPDH.	Unpaired	t test, *p < 0.05 (n = 3). Each old and young iNPC-As sample (n = 3/group) was assessed in three independent 
experimental repeats and results are expressed as the mean of the three repeats/sample. Error bar ± SD.
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F I G U R E  5 Altered	oxidative	stress	capacities	in	old	donor-derived	astrocytes.	(a)	Representative	immunofluorescence	images	of	ROS	
in young and old donor-derived iNPC-As at baseline or treated with 0.0016% V/V of β-mercaptoethanol in culture medium as antioxidant 
negative	control.	Cellular	ROS	levels	were	assessed	in	iNPC-As	by	CellROX® Reagent, Scale bar (10 µm). (b) Quantitative image analysis 
of	ROS	detected	by	CellROX® Reagent in young and old donor-derived iNPC-As. Fluorescence intensity was assessed using Columbus 
Software.	Unpaired	t test, ****p < 0.0001 (n	=	3).	(c)	Quantitative	imaging	analysis	of	ROS	time-course	detected	by	CellROX® Reagent in 
young	and	old	donor-derived	iNPC-As.	Fluorescence	intensity	was	assessed	using	Columbus	Software.	Unpaired	t test between young 
and old iNPC-As at each timepoint, **p < 0.01, *p < 0.05 (n	=	3).	For	the	CellROX	data,	each	old	and	young	iNPC-As	sample	(n = 3/group) 
was assessed in three independent experimental repeats each containing three technical replicates. Results are expressed as the mean of 
the	three	experimental	repeats/sample.	Error	bar	±	SD.	(d)	Representative	images	of	Western	blot	analysis	of	NRF2	and	SOD1.	Cells	were	
incubated	in	serum-free	media	for	24	h	and	harvested	(UT	=	untreated,	SF	=	serum-free	media).	Protein	from	young	and	old	donor-derived	
iNPC-As was separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis followed by immunoblotting. (e) Densitometric 
quantification	of	NRF2	and	SOD1	(F)	protein	levels,	normalised	to	GAPDH.	Two-way	ANOVA,	****p < 0.0001, *p < 0.05, **p < 0.01. For 
the WB data, each old and young iNPC-As sample (n = 3/group) was assessed in three independent experimental repeats and results are 
expressed as the mean of the three repeats/sample. Error bar ± SD. (g) Representative images of yH2AX staining and foci/cell quantification 
(H) in young and old donor-derived iNPC-As, Scale bar (10 µm). Results are expressed as the means of three independent experimental 
repeats/sample,	each	containing	three	technical	replicates/experiment.	Error	bars	±	SD.	Unpaired	t test, ****p < 0.0001 (n = 3).
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2.6  |  Older donor-derived iNPC-As are less 
supportive to MNs upon pro-inflammatory stress
So far, our results demonstrate that iNPC-As derived from fibro-
blasts of donors from different age groups successfully recapitu-
late important transcriptional and functional age-related features. 
To probe the ageing astrocyte phenotype in more depth, we 
wanted to assess one of the most important functions fulfilled by 
astrocytes in vivo, that is, their ability to support neurons through-
out	the	ageing	process	and	under	stressful	conditions.	In	particu-
lar, recent studies have shown that, as astrocytes are exposed to 
microglia-secreted pro-inflammatory cytokines in the ageing brain 
(Liddelow et al., 2017), they become less supportive to neurons. 
Therefore,	 we	 tested	 the	 effect	 of	 IL-1β treatment, as this pro-
inflammatory cytokine is released by microglia in the CNS dur-
ing ageing (Clarke et al., 2018) and after injury (Pineau & Lacroix, 
2007).
To functionally test our cell model, both young and old donor-de-
rived	iNPC-As	were	exposed	to	IL-1β for 6 h, washed to remove any 
residual cytokine and were then co-cultured with human iPSC-de-
rived motor neurons (Figures S3 and S4) to test their ability to sup-
port neurons when challenged with inflammatory stress.
Caspase-3, a master regulator of apoptosis, that catalyses the 
cleavage of many key cellular proteins, was used to assess neuro-
nal	 health	 in	 co-culture.	 Immunostaining	 data	 showed	 that	 both	
young and old donor-derived iNPC-As are equally able to support 
neuronal survival under basal conditions (Figure 6a,b). Treatment 
of	iNPC-As	with	IL-1β, however, led to a significant 3-fold increase 
of caspase-3 and apoptotic nuclear fragmentation in MAP2+ cells 
cultured	with	old	donor	iNPC-As	(Figure	6a,b).	In	contrast,	neurons	
cultured with young donor iNPC-As did not show any difference be-
tween	conditions,	that	is,	iNPC-As	untreated	or	pretreated	with	IL-1β 
(Figure	6a,b).	 In	order	to	understand	the	causes	of	this	differential	
response,	 we	 assessed	 the	 effect	 of	 IL-1β treatment on iNPC-As, 
with a particular focus on NFκB. NFκB is a transcription factor that 
regulates multiple aspects of innate and adaptive immune functions 
and	represents	a	central	mediator	of	 inflammatory	responses.	Our	
results	 show	 that	 IL-1β does not affect astrocytes survival (Figure 
S5); however, it cause a 4-fold increase in nuclear activation of NFκB 
compared to young donor iNPC-As (Figure 6D). Furthermore, old 
donor iNPC-As become more reactive, displaying higher levels (in-
tensity/pixel) of GFAP and vimentin compared to their baseline ex-
pression level (Figure 6e-h).
3  |  DISCUSSION
Astrocytes are the largest group of glial cells in the CNS and are respon-
sible for vital homeostatic functions. Several studies have reported that 
glial cells are potentially more affected by the ageing process than neu-
rons.	 In	particular,	astrocytes	present	dramatic	transcriptional	 (Soreq	
et al., 2017) and functional changes during ageing (Gemma et al., 2007; 
Lynch et al., 2010; Rea et al., 2018) that hinder their ability to maintain 
homeostasis in the CNS and support neurons throughout their life 
course.
Ageing is a leading risk factor for multiple neurodegenerative 
diseases, so it is fundamental to recapitulate age-related character-
istics in cells that contribute to and are actively involved in diseases. 
It	is	well	known	that	ageing	and	neurodegeneration	share	common	
mechanisms including increased oxidative stress, excitotoxicity and 
inflammation. Alzheimer's disease (AD), Parkinson's disease (PD) and 
amyotrophic lateral sclerosis (ALS) are three common adult-onset 
neurodegenerative diseases known to involve astrocyte dysfunc-
tion (Booth et al., 2017; González-Reyes et al., 2017; Haidet-Phillips 
et al., 2011; Meyer et al., 2014). As a consequence, lack of human 
in vitro models that mimic the functional features of astrocytes in 
young and old age is a limitation to studying mechanisms and poten-
tial therapies involved not only in maintaining brain health, but also 
in combatting neurodegenerative diseases and other neurological 
conditions.
In	this	study,	we	successfully	derived	iNPC-As	from	young	do-
nors (5 months-3 years) and compared them to iNPC-As derived 
from	older	donors	(42–56	years).	Comparative	transcriptomic	anal-
ysis demonstrated that the transcription profile of iNPC-As from 
old donors recapitulates transcriptional features of laser-captured 
PM astrocytes from adults of a similar age. Although this compari-
son is affected by the different origin of the cells (ex vivo vs. in vitro) 
and their neighbouring environment (enriched laser-captured cell 
population vs. pure cell population), strikingly, the transcriptional 
differences between iNPC-As from young and old donors display 
~80% overlap with the differences discriminating between PM 
and foetal primary human astrocytes. This indicates that iNPC-As 
derived from directly converted iNPCs retain astrocyte-relevant 
ageing	 transcriptomic	 features.	 In	 addition,	 we	 observed	 a	 con-
sistent skew in gene expression upregulation in young astrocytes 
compared to their older counterpart, suggesting an effect of age 
on transcription. A similar pattern was also recently reported in a 
transcriptomic study comparing young and old donor fibroblasts 
(Sarkar et al., 2020). When we specifically looked at the pathways 
described by these transcriptional changes, we identified multiple 
pathways involved in ageing and senescence, that is, p53 signal-
ling, oxidative stress, DNA damage and inflammatory response. 
Indeed,	we	confirmed	these	transcriptional	changes	at	functional	
level. We show here that direct conversion of fibroblasts to iNPCs 
and differentiation to iNPC-As retains key age-related cellular 
characteristics. TERF2, an enzyme involved in telomere organisa-
tion, decreases significantly with age in fibroblasts and derived 
iNPC-As recapitulate this decrease in expression level following 
reprogramming. Consistently, telomere length is lower in old iN-
PC-As. Moreover, our model reproduces the global loss of the 
heterochromatin marker (H3K9me3) and nuclear organisation ab-
normalities reported in ageing and neurodegenerative conditions 
(Miller et al., 2013; Tang et al., 2017). Major Lamin A disruption oc-
curs in Hutchinson-Gilford progeria syndrome (HGPS), as a conse-
quence of mutations in the gene encoding for this protein, that is, 
LMNA. HGPS is a rare genetic condition that leads to accelerated 
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ageing and brain development abnormalities (Gonzalo et al., 2017), 
demonstrating the link between nuclear envelope integrity, age-
ing and neurodegeneration. At a cellular level, HGPS displays a 
number of characteristics typical of ageing cells including loss of 
heterochromatin, nuclear lobulation and increased DNA damage 
(Ghosh & Zhou, 2014). Expression of progerin, a truncated form of 
LMNA, is used to induce ageing in iPSC models (Miller et al., 2013). 
Although this approach recapitulates some aspects of cellular age-
ing, it still carries the substantial limitation of introducing a patho-
genic	mutation	to	model	a	physiological	process.	In	addition,	this	
strategy might create confounding phenotypes when applied in 
the study of neurodegenerative conditions other than HGPS.
Without inserting any mutation, our data show that iNPC-As 
derived from directly reprogrammed iNPCs from older individuals 
display decreased histone H3 K9 trimethylation, accumulation of 
DNA damage and mild Lamin A/C disruption with associated loss of 
nuclear integrity, leading to nuclear ‘leakiness’. This phenotype has 
been reported in several ageing studies and is associated with loss of 
integrity of the NuPC (D’Angelo et al., 2009; Lord et al., 2015), thus 
favouring uncontrolled protein diffusion and loss of the normal com-
partmentalisation between the nucleus and the cytoplasm.
In	 addition	 to	 this	 impairment,	 the	 present	 report	 reveals	 a	
significant decrease in three nucleocytoplasmic transporters, 
RANBP17,	 IPO5	 and	 XPO1,	 which	 play	 major	 roles	 in	 regulat-
ing nuclear import and export. Mertens et al. (2015) have pre-
viously reported that RANBP17 expression decreases in ageing 
cells and directly reprogrammed neurons from old donor fibro-
blasts,	 but	 not	 in	 iPSCs.	 Our	 data	 reveal	 that	 the	 age-related	
decrease in nucleocytoplasmic transport is bidirectional and is 
not limited to RANBP17. Nucleocytoplasmic transport has re-
cently emerged as a key dysregulated pathway in neurodegen-
erative disorders. Several studies have shown how mutations in 
genes causing amyotrophic lateral sclerosis and frontotemporal 
dementia (ALS/FTD) lead to aberrant nucleocytoplasmic par-
titioning of ALS-causing gene products and that this dysregula-
tion includes both subcellular mislocalisation and cytoplasmic 
inclusions (Ferreira, 2019). For instance, it has been reported how 
mutations in TAR DNA-binding protein 43 (TDP43) and Fused in 
Sarcoma (FUS) lead to accumulation of these proteins within the 
cytoplasm and mislocalisation from the nucleus, thus affecting 
nucleocytoplasmic transport (Mackenzie et al., 2010). More re-
cently, studies also revealed that the GGGGCC repeat expansion 
in C9orf72 compromises nucleocytoplasmic transport (Freibaum 
et	al.,	2015;	 Jovičić	et	al.,	2015).	Further	evidence	 revealed	 that	
this pathway is also impaired in AD (Eftekharzadeh et al., 2018) 
and Huntington's disease (HD) (Gasset-Rosa et al., 2017; Grima 
et	al.,	2017).	Specifically,	XPO1	has	been	identified	as	an	import-
ant transporter for many proteins involved in neurodegenerative 
diseases (Chan et al., 2011; Ederle et al., 2018; Zhong et al., 2017). 
XPO1	is	an	essential	nuclear	export	receptor	(Stade	et	al.,	1997),	
which recognises cargoes with the leucine-rich nuclear export se-
quence (NES) (Dong et al., 2009). Recently, a study in C. elegans 
showed	that	ALS-linked	mutant	SOD1,	when	misfolded,	exposes	
a	normally	buried	NES-like	sequence,	leading	to	XPO1-dependent	
nuclear export. This has been proposed as a potential protective 
mechanism	against	misfolded	SOD1	proteotoxicity	 (Zhong	et	al.,	
2017), which, in light of our data, is likely to decrease with age, 
thus shifting the balance between accumulation of toxic proteins 
and neuroprotective cellular defences. A similar mechanism has 
also been reported for CAG repeats expansions associated with 
polyglutamine (polyQ) diseases, in which exportin 1 regulates the 
nucleocytoplasmic distribution of expanded polyQ protein (Chan 
et	al.,	2011).	Decreased	expression	of	XPO1	protein	levels	in	vivo	
contributes to the accumulation of expanded polyQ protein in 
the nucleus of symptomatic polyQ transgenic mice. This process 
drives the nuclear accumulation of the disease protein, and thus, 
the cell nucleus becomes an important site of pathology in polyQ 
diseases, where transcription is affected.
Additional stress that can significantly affect transcription, 
and	also	translation,	 is	represented	by	accumulation	of	ROS	that	
damage lipids, protein and nucleic acids, which are commonly 
detected as biochemical footprints in aged tissue (Brawek et al., 
2010;	Lukiw	et	al.,	2012).	Oxidative	stress	is	caused	by	an	imbal-
ance	in	the	redox	state	of	the	cell,	by	overproduction	of	ROS	or	by	
impairment	of	 the	 antioxidant	defence	 system.	 In	particular,	 the	
CNS	 is	vulnerable	 to	 the	effects	of	ROS	due	 to	 its	high	demand	
for oxygen, and its abundance of substrates highly susceptible to 
oxidative modification. Neurons are postmitotic and have a very 
high energy demand, and thus are vulnerable to oxidative insults. 
Consistently, it has been shown that Nrf2 levels and activity are 
significantly higher in the longest-lived rodents compared to 
short-lived mice (Lewis et al., 2015). Surprisingly, however, neu-
rons have weak endogenous antioxidant defences, as the main an-
tioxidant pathways such as the Nrf2 pathway are silenced during 
development within neurons (Bell et al., 2015). Therefore, neurons 
rely heavily on non-cell autonomous antioxidant support from as-
trocytes. Antioxidant defences, however, have been shown to sig-
nificantly decrease during ageing in astrocytes themselves, with 
consequent	accumulation	of	ROS	(Ishii	et	al.,	2017).	A	recent	study	
showed that Nrf2 overexpression in astrocytes protects against 
F I G U R E  6 Old	donor-derived	iNPC-As	are	less	supportive	to	MNs	after	pro-inflammatory	stress	with	IL-1β. (a) Representative images 
of human MN and young or old donor-derived astrocytes co-culture. Scale bar (10 µm). (b) Quantitative imaging analysis of percentage of 
caspase-3	in	MAP2+	cells.	Two-way	ANOVA,	****p < 0.0001. (c) Representative images of NFκB staining and NFκB nuclear activation (d) 
in	untreated	and	treated	with	IL-1β	(20	ng/ml)	young	and	old	donor-derived	iNPC-As.	Scale	bar	(10	µm).	Two-way	ANOVA,	****p < 0.0001. 
(e)	Representative	images	and	quantitative	analysis	(f)	of	vimentin	staining	in	untreated	and	treated	with	IL-1β (20 ng/ml) young and old 
donor-derived	iNPC-As.	Scale	bar	(10	µm).	Two-way	ANOVA,	****p < 0.001. (g) Representative images and quantitative analysis (H) of 
GFAP	staining	in	untreated	and	treated	with	IL-1β	(20	ng/ml)	young	and	old	donor-derived	iNPC-As.	Scale	bar	(10	µm).	Two-way	ANOVA,	
***p < 0.001. Results are expressed as the means of three independent experimental repeats/sample (n = 3/group), each containing three 
technical	replicates/experiment.	Error	bars	±	SD.	In	each	experiment,	at	least	150	cells/well	were	assessed
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cerebral hypoperfusion, thus suggesting that Nrf2 overexpression 
specifically in astrocytes is protective, exerting beneficial effects 
through	 repression	 of	 inflammation	 (Sigfridsson	 et	 al.,	 2018).	 In	
neurodegenerative diseases such as multiple sclerosis (MS), for ex-
ample, astrocytes in active lesions display an increase of cytoplas-
mic accumulation of oxidised proteins and lipids (Horssen et al., 
2008) and nuclear accumulation of oxidised DNA (Haider et al., 
2011). As the antioxidant defences of astrocytes decrease with 
age, they are unable to provide optimal support to neighbouring 
neurons, which start accumulating oxidative DNA damage, thus 
leading to an increased susceptibility to a number of age-related 
diseases	and	cognitive	decline	(Oksanen	et	al.,	2019).	Because	of	
its crucial role in ageing and neurodegeneration, it is important 
that human in vitro models of astrocytes can recapitulate this 
age-dependent functional decline.
Strikingly, in the present report, we found that old iNPC-As ex-
hibited	a	higher	baseline	level	of	ROS	and	DNA	damage	compared	
to young iNPC-As. Furthermore, when iNPC-As were stressed by 
serum starvation, old iNPC-As required more time to recover to 
baseline	 ROS	 levels,	 as	 the	 levels	 of	 both	 NRF2	 and	 SOD1	were	
lower in old iNPC-As compared to young iNPC-As, both at baseline 
and following acute stress. Thus, our model recapitulates the age-re-
lated decrease in antioxidant defences reported from in vivo studies 
and	provides	an	explanation	for	the	increased	level	of	ROS	seen	in	
these cells.
It	 is	well	known	that	oxidative	stress	plays	a	central	role	in	the	
pathophysiology of neurodegenerative diseases, such as ALS, AD, 
HD and PD (Li et al., 2013; Niedzielska et al., 2016) where the antiox-
idant response has been proposed as a potential therapeutic target. 
Oxidative	stress	may	provoke	cellular	damage,	dysregulation	of	DNA	
damage repair and mitochondrial dysfunction, all hallmarks of the 
ageing process as well as neurodegenerative disorders (Allen et al., 
2019; Shibata & Kobayashi, 2008).
Toxicity from free radicals also contributes to inflammation, 
another	 major	 component	 in	 neurodegeneration.	 In	 our	 study,	
we showed the age-related differential responses of iNPC-As in 
their ability to support neurons in co-culture upon acute stimu-
lation	 with	 the	 inflammatory	 cytokine	 interleukin-1	 beta	 (IL-1β). 
Our	data	 suggest	 that	 this	 is	 due	 to	 an	 exaggerated	 response	of	
old	donor-derived	iNPC-As	to	IL-1β stimulation, resulting in stron-
ger nuclear activation of NFκΒ and higher levels of expression of 
GFAP and vimentin. Although already at baseline old and young 
iNPC-As differ in the activation of several stress defence mech-
anisms, we did not detect a significant difference in their ability 
to	support	neuronal	survival,	measured	as	Casp3	activation.	Other	
more subtle parameters, however, could be compromised in neu-
rons cultured with older non stimulated astrocytes. Recent studies 
in post-mortem brains and C. elegans, in fact, have reported that 
dendrite restructuring, neuronal sprouting, and synaptic deteriora-
tions are subtle changes commonly detected in physiological brain 
ageing, rather than neurodegeneration (Henstridge et al., 2015; 
Hess et al., 2019).
GFAP and vimentin are classical astrocytic markers that increase 
in expression as astrocytes become more reactive with age (Boisvert 
et	al.,	2018;	Clarke	et	al.,	2018;	Wu	et	al.,	2005).	Indeed,	astrocytes	
have been described as going through activation stages ranging from 
mild to severe in response to physiological ageing or pathological 
and external insults, respectively. Mild reactivity is characterised by 
low levels of hypertrophy and expression of GFAP, while severe re-
activity, for example in response to pro-inflammatory stimuli, results 
in significant hypertrophy and GFAP expression increase (Sofroniew 
&	Vinters,	2010).	Our	baseline	and	IL-1b	treatment	data	overall	reca-
pitulate these characteristics, where old iNPC-As display larger area, 
as well as higher levels of GFAP and vimentin compared to young 
iNPC-As at baseline. GFAP and vimentin levels then further increase 
upon	IL-1b	treatment.	In	addition,	increased	astrocyte	reactivity	has	
been reported in several neurodegenerative disorders. For example, 
studies in AD brain samples and mouse models detected amyloid 
plaques surrounded by reactive astrocytes, with higher expression 
of	GFAP	(Li	et	al.,	2011).	Interestingly,	the	increased	number	of	re-
active astrocytes frequently correlates with the extent of cognitive 
decline	(Kashon	et	al.,	2004).	In	patients	with	PD,	astrocyte	reactiv-
ity has been seen in the substantia nigra pars compacta (Hirsch & 
Hunot, 2009), while in ALS patients, it has been observed in suscep-
tible regions and the degree of reactivity correlates with the severity 
of neurodegeneration (Haim et al., 2015).
In	conclusion,	the	present	study	demonstrates	that	direct	con-
version of fibroblasts to iNPCs and subsequent differentiation into 
iNPC-As results in an in vitro model able to retain key hallmarks of 
the ageing process. Although not investigated in this study, it is likely 
that the iNPCs themselves and all cells derived from them would 
preserve ageing features through this reprogramming methodology. 
It	is,	in	fact,	unlikely	that	iNPCs	would	not	carry	ageing	features	and	
these would be gained in iNPC-As is only 7 days of differentiation. 
This is of extreme importance, as this in vitro tool allows for more 
accurate and physiologically relevant modelling of ageing and dis-
ease, without the need to introduce age-inducing genetic mutations 
or insults.
Interestingly,	 our	 results	 are	 in	 apparent	 contrast	 with	 the	
study by Sheng et al. (2018) who achieved direct reprogramming 
of peripheral blood cells (PBC) into iNPCs through a fast pro-
tocol (21 days). Consistent with our data, the authors observed 
retention of telomere length and a partial ageing signal in their 
transcriptomic study in iNPCs at low passage number. Both tran-
scription profile and DNA methylation (DNAm) status, however, 
were largely affected by cell culture expansion and passaging >18 
passages, which is our cut-off for iNPC culture. Similarly, Sardo 
et al. (2017) reported loss of ageing features in iPSCs derived from 
donors	aged	21–100	at	passage	28	compared	to	8.	Although	we	
did not assess the DNAm status of our iNPCs or iNPC-As, our re-
sults would indicate that the ability of our reprogramming method 
to retain ageing features is likely to be related to several different 
aspects, including cells of origin, conversion efficiency, factors 
used during the conversion phase and, likely the most important 
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factor, time in culture. PBCs present, in fact, several advantages 
for cell reprogramming, as an abundant source of cells; however, 
they are very susceptible to DNAm changes due to environmental 
factors and have intrinsically higher self-renewal ability compared 
to fibroblasts (Ciccarone et al., 2018). These characteristics could 
contribute to the ability of the cells to retain ageing features after 
reprogramming.	 In	 addition,	 during	 PBC	 conversion	 to	 iNPCs,	
Sheng et al. (2018) selected iNPC colonies, thus introducing clonal 
selection. They also utilised a number of factors known to stim-
ulate	self-renewal,	such	as	CHIR,	a	WNT	signalling	activator,	and	
LIF,	 a	 JAK-STAT	activator,	 involved	 in	pluripotency	maintenance	
in	 vitro	 (Onishi	 &	 Zandstra,	 2015).	 As	 our	 transcriptomic	 study	
shows, WNT signalling downregulation is a feature of aged as-
trocytes, whether these are reprogrammed or from PM tissues, 
indicating that this pathway plays an important role in the age-
ing process. Hence, its upregulation might lead to rejuvenation 
processes	 likely	 to	 affect	 ageing	 feature	 retention.	 It	 would	 be	
interesting	 to	 test	whether	LIF	or	CHIR	addition	 to	our	cultures	
would alter the ageing phenotype of the iNPCs and deriving cells.
Surprisingly,	the	use	of	the	Yamanaka	factors,	that	is,	OKSM,	did	
not affect the ability of our methodology to retain ageing features. 
In	this	context,	Ocampo	et	al.	(2016)	and	Sarkar	et	al.	(2020)	test	the	
expression of the reprogramming factors only for a short ‘pulse’ and 
they both observe loss of ageing markers and de-methylation, indi-
cating	that	even	short	exposure	to	the	Yamanaka	factors	is	enough	
to	cause	loss	of	ageing.	Interestingly,	however,	Ocampo	et	al	report	
that, upon ‘switching off’ the expression of the transcription factors, 
some	 ageing	 markers	 are	 regained.	 One	 interesting	 hypothesis	 is	
that also in our protocol in the first 48 h the fibroblasts might ex-
perience a de-methylation and rejuvenation wave, which enables 
the reprogramming, but that is then halted as iNPC differentiation 
starts, hence allowing for ageing epigenetic markers to be regained. 
Indeed,	DNAm	analysis	of	our	 iNPC	cultures	at	different	stages	of	
conversion and differentiation would test this hypothesis and clar-
ify the mechanisms involved in ageing preservation shown in this 
manuscript.
In	 summary,	 the	 ability	 of	 this	 model	 to	 recapitulate	 the	 be-
haviour of human astrocytes throughout the process of ageing as 
well as the crosstalk with age-matched neurons has the unique and 
unprecedented potential to answer important questions about the 
physiology and the pathophysiology of the CNS and to provide a 
powerful tool for novel therapeutic approaches for age-related neu-
rodegenerative and neurological disorders.
4  |  E XPERIMENTAL PROCEDURES
4.1  |  Direct reprogramming of skin fibroblasts to 
iNPCs
Direct conversion was conducted with a modified version of the 
protocol	described	previously	in	Meyer	et	al.	(2014).	One	lakh	fi-
broblasts were seeded in a well of a six-well plate and treated with 
retroviral vectors for OCT3, SOX2, KLF4 and c-MYC (Meyer et al., 
2014). After 48 h, the medium was switched to NPC conversion 
medium, consisting of DMEM/F12, 1% N2, 1% B27, EGF (40 ng/ml) 
and	FGF	(20	ng/ml).	Typically,	after	2–4	days	60–80%	of	the	fibro-
blasts changed shape to smaller morphology; some lifted and cre-
ated sphere-like structures, some started proliferating in rosettes 
or simply remained attached and changed morphology. These cells 
proliferated quickly and were split when 100% confluent. These 
were collected or lifted using Accutase (StemPro® Accutase® Cell 
Dissociation Reagent, Gibco) and, depending on the density and 
their growth rate, they were expanded in multiple wells of a six-
well plate or a 10-cm dish coated with human fibronectin (5 μg/ml; 
Millipore)	over	a	period	of	18–21	days.	After	this	first	expansion	
period, during which the fibroblasts that did not reprogramme 
were diluted and eventually lost during iNPC expansion, cells were 
stained for Nestin and PAX6 to establish successful iNPC conver-
sion. Typically, successful conversion is defined as yielding >95% 
cell positive for PAX6 and Nestin. This pure iNPC population was 
then expanded and stored for up to 18 passages. The lines used 
in this study all yielded a purity >98% regardless of the age of the 
donor (Figure S1).
4.2  |  Differentiation of iNPCs into iNPC-As
To induce astrocyte differentiation, the iNPCs between pas-
sages	 12–18	 were	 plated	 in	 medium	 composed	 of	 DMEM,	 10%	
foetal bovine serum (FBS) (Life Science Production), 1% Penicillin-
Streptomycin (Lonza Biowhittaker), 0.2% N2-supplement (Gibco 
Life Tech) in a 10-cm dish coated with human fibronectin (Millipore). 
Astrocytes	were	 allowed	 to	 differentiate	 for	 7	 days.	 In	 all	 experi-
ments, iNPCs from both young and old donor were passage matched 
within ±2 passages.
4.3  |  Differentiation of iPSCs into motor neurons 
(MNs)
Motor neuron differentiation (Figure S3) of iPSCs was performed 
using the modified version dual SMAD inhibition protocol (Du et al., 
2015). This protocol typically yields ~90% ChAT+ MNs.
4.4  |  Co-culture of iNPC-As and MNs
Motor	neuron	progenitors	were	plated	at	a	density	of	1	×	104 cell/
well onto matrigel-coated 96-well plates in the presence of 10 µM 
rock inhibitor on day 20 of differentiation. The MNPs were dif-
ferentiated into MN until day 40 when the astrocytes were added 
on	 the	 top	 of	 the	motor	 neurons	 at	 a	 density	 of	 0.8	 ×	 104 cell/
well. The co-cultures were cultured for three days, and then, the 
cells were fixed and processed for immunofluorescence staining 
(Figure S4).
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4.5  |  Microarray analysis
Microarray analysis of human foetal astrocytes (purchased from 
ScienCell; pool of foetal astrocytes isolated from human brain cortex), 
PM astrocytes laser-captured from human brain and iNPC-As repro-
grammed	from	fibroblast	donors	was	performed	at	SITraN,	University	
of Sheffield (Table S2). Foetal astrocytes were run on GeneChip™ 
Human Gene 2.0 ST Array, while postmortem astrocytes and iNPC-
As	were	run	on	GeneChip™	Human	Genome	U133	Plus	2.0	Array.	All	
the data were already available at the beginning of the study and all 
had obtained relevant ethical approval. The quality of array data CEL 
files was assessed using the Affymetrix Expression Console software. 
Normalisation, with all the transcripts normalised by beta-tubulin and 
GAPDH, and harmonisation across Chip files was obtained using the 
Robust Multi-Array (RMA) algorithm. Normalised data have been sub-
mitted	as	a	Pivot	Table	to	the	Online	Research	Data	 (ORDA)	reposi-
tory (link: 10.15131/shef.data.12162282). Differential gene expression 
between	samples	was	determined	using	Qlucore	Omics	Explorer	after	
normalisation. The software was used also for Principal Component 
Analysis (PCA) and hierarchical clustering. To access the functions 
of genes found in the meta-analysis, the Database for Annotation, 
Visualisation	 and	 Integrated	 Discovery	 (DAVID,	 https://david.ncifc	
rf.gov/) and Panther (http://www.panth erdb.org/). The website Human 
Genomic Resources (HAGR, http://genom ics.senes cence.info/) was 
used to identify ageing-related genes.
4.6  |  RNA Isolation and quantitative real-time 
polymerase chain reaction (qPCR)
RNA was harvested using the RNAeasy Mini kit (Qiagen), and 
total RNA was reverse-transcribed with the High Capacity cDNA 
Reverse Kit (Applied Biosystem) according to the manufacturer's 
instructions.
Primers were designed using Primer-BLAST to assess tran-
scriptional changes in a number of selected genes reported by 
microarray analysis identified through HAGR and validated age-
ing markers (Table S4). Samples were loaded at a concentration of 
12.5 ng/μl	per	well.	qPCR	was	performed	using	2x	SYBR	Green/
Rox PCR Master Mix (Bimake.com) and forward and reverse prim-
ers (final concentration 250 nM), to a total volume of 20 µl. After 
initial denaturation at 95°C for 10 min, templates were ampli-
fied by 40 cycles at 95°C for 15 s and 60°C for 1 min, using the 
Stratagene MX300P machine. At the end, a dissociation curve was 
created to ensure amplification of a single product and the ab-
sence of primer dimers.
GAPDH was tested against other housekeeping genes, includ-
ing	B-actin,	RLP13A	and	U1.	GAPDH	showed	the	most	consistent	
and stable expression across samples of different ages as well as be-
tween fibroblasts and astrocytes. Hence, GAPDH was amplified on 
each plate to normalise expression levels of target genes between 
different samples using the ΔΔCt	 calculation	 (ABI)	 and	 to	 assess	
assay reproducibility.
4.7  |  Telomere length measurement
DNA from iPSC- and iNPC-derived young and old astrocytes 
was	extracted	with	the	DNeasy	Blood	&	Tissue	Kit	(QIAGEN)	ac-
cording to the manufacturer's protocol. Telomere length of iPSC 
and iNPC-derived astrocytes was measured using the Absolute 
Human Telomere Length quantification qPCR assay Kit (ScienCell 
Research	Laboratories,	San	Diego,	CA,	USA)	according	to	the	man-
ufacturer's instructions. A single copy reference (SCR) primer set 
recognises and amplifies a 100-bp-long region on human chromo-
some 17 and is used as a reference for data normalisation. The 
reference genomic DNA sample with known telomere length was 
used as reference for calculating the Telomere Length of iPSC 
(Table S5) and young and old iNPC-derived astrocytes. qPCR prod-
ucts were performed on a C1000 Touch™ thermos Cycler CFX96™ 
Real-Time System (Bio-Rad), and qPCR data were analysed using 
CFX Manager™ software (Version 3.1) (Bio-Rad) and GraphPad 
Prism (Version 8).
4.8  |  iNPC-A treatment for stress response 
assessment and cell collection
Serum starvation experiments were carried out by washing the cells 
with PBS twice and changing the culture medium to fresh media 
without FBS at day 6.
On	day	7,	iNPC-As	were	washed	twice	with	PBS	to	remove	me-
dium residuals and harvested by cell scraping. The cell pellets were 
stored	at	−80°C	until	processed	for	RNA	or	protein	extraction.
4.9  |  IL-1β treatment to induce inflammation in 
iNPC-As and CC
Astrocyte activation was stimulated by the addition of fresh medium 
containing	recombinant	human	IL-1β (20 ng/ml, R&D Systems) and 
incubated for 20 min for evaluation of NF-κB translocation, for 24 
and 72 h and for reactive gliosis.
For the co-culture experiments, young and old astrocytes were 
stimulated	with	recombinant	human	IL-1β (20 ng/ml R&D Systems), 
for 6 h and then gently washed three times with warm PBS to fully 
eliminate	residual	IL-1β in the culture. After that the astrocytes were 
seeded on the top of the MNs in the presence of neuronal medium. 
The co-cultures were maintained at 37°C in a humidified atmosphere 
with	5%	CO2 for 3 days when the analyses of cell death was per-
formed.	Young	and	old	untreated	astrocytes	were	used	as	controls.
After the treatment, the cells were fixed and stained for vimen-
tin as a astrocytic marker, active caspase three to detect apoptotic 
cells, MAP2 (neuronal marker) was used as a marker that define 
the	boundary	of	cells	and	DAPI	for	nuclear	staining.	A	quantitative	
imaging analysis of the apoptotic neurons was conducted through 
the	 Opera	 Phenix™	 High	 Content	 Screening	 System	 at	 ×40	mag-
nification	 using	 the	 Harmony	 High-Content	 Imaging	 and	 Analysis	
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Software. Quantification of apoptotic neurons was assessed for both 
treated and untreated cells, whereby only cells that stained positive 
for MAP2 were evaluated for caspase 3 staining. Twenty fields per 
well of a 96-well plate were randomly selected, scanned and staining 
quantified, thus leading to the quantification of about 100 cells/well. 
Each co-culture condition was run in triplicate (technical repeats).
4.10  |  Immunocytochemistry (ICC) iNPC-As
Ten thousand iNPC-As were plated per well in 96-well plates at day 
6 of differentiation and fixed 24 h after seeding with 4% paraformal-
dehyde (PFA) for 10 min. Cells were washed three times with phos-
phate-buffered saline (PBS) following which blocking (PBS, 5% horse 
serum and 0.05% Triton X-100) was applied for 1 h. All primary anti-
bodies were diluted in blocking solution and their dilution and sup-
pliers	are	listed	in	Table	S6.	Incubation	of	the	primary	antibody	was	
performed overnight at 4°C. The next day, cells were washed three 
times in PBS before the secondary antibody (Table S7) in blocking 
solution was applied for 1 h at room temperature. Hoechst (Hoechst 
33342, Trihydrochloride, Trihydrate, Life tech) diluted 1:6000 was 
added for 5 min to visualise the nucleus. Cells were then washed 
twice	with	PBS	and	imaged	using	the	Opera	Phenix	high-content	im-
ager (PerkinElmer).
4.11  |  Immunocytochemistry (ICC) MNs and CC
For immunostaining, after three days of co-culture (CC), cells were 
washed with PBS and fixed with 4% paraformaldehyde for 15 min at 
room temperature. After fixation samples were washed three times 
with PBS, incubated with 0.3% Triton X-100 in PBS (Sigma) for 5 min 
then blocked by incubation with PBS containing 5% donkey serum 
(DS) (Millipore) for 1 h. After blocking, cell cultures were incubated 
with primary antibodies diluted in PBS containing 1% of DS over-
night. Cells were washed with PBS three times. Then, secondary 
antibodies were added to cells and incubated for 1 h. The samples 
were washed with PBS three more times and incubated with 1.0 mg/
ml	4,6-diamidino-2-phenylindole	(DAPI)	for	nuclear	staining.	The	pri-
mary and secondary antibodies were used at the dilutions indicated 
in tables S6 and S7. All experiments included cultures where the pri-
mary antibodies were not added, and non-specific staining was not 
observed in these negative controls.
4.12  |  Oxidative stress assay
Seven thousand iNPC-As were plated per well in 96-well plates 
at	day	5	of	differentiation	 in	 complete	 astrocyte	medium.	On	day	
6, medium was replaced either with complete or with serum-free 
astrocyte medium for 12 hours or with complete medium plus 
0.0016% V/V β-mercaptoethanol as a negative control. After 12 h, 
medium was replaced in all conditions with complete astrocyte 
medium	and	CellROX	baseline	measurements	were	collected,	using	
the	Opera	Phenix	 Imaging	System.	A	 time-course	experiment	was	
also	 performed,	 in	 which	 CellROX	 measurements	 were	 collected	
every	2	h	for	6	h.	CellROX® Reagent (Life Technologies) was used at 
a final concentration of 2.5 μM as per manufacturer's instructions 
and	incubated	with	cells	for	30	min	at	37°C.	CellROX® Reagent was 
then removed, and cells were washed three times with PBS before 
imaging.
4.13  |  Nuclear isolation and dextran influx assay
Two 10-cm dishes of iNPC-As (two million cells) were used for nuclei 
isolation. After two washes with PBS, accutase was added and the 
plates were incubated at 37°C for 3 min. Accutase was diluted with 
3 ml PBS, and the cells were collected in a tube and spun at 200 g 
for 4 min. The pellet was washed twice with PBS and then left to 
dry. 400 µl of hypotonic lysis buffer (10 mM HEPES, 1.5 mM MgCl2, 
10	mM	KCl,	0.5	mM	DTT,	20	µl/ml	PIC)	was	added	to	the	pellet.	The	
lysate was passed through a 19 g needle five times, left for 10 min on 
ice and then spun down at 800 g for 3 min at 4°C to separate the nu-
clear fraction from the cytoplasmic. The supernatant was discarded 
(cytoplasmic	fraction),	while	250	µl	of	IP	lysis	buffer	(150	mM	NaCl,	
50 mM HEPES, 1 mM EDTA, 1 mM DTT, 0.5% (v/v) Triton™ X-100, 
20	µl/ml	PIC,	pH	8.0)	with	60	µl	of	PMSF	(phenylmethanesulfonyl)	
was added to the nuclear pellet. The lysate was passed through a 
25	g	needle	five	times	and	then	left	for	30	min	on	ice.	It	was	spun	
at 10,000 g for four minutes at 4°C, and the supernatant was kept 
as the nuclear fraction. Nuclei were stained with Hoechst (Hoechst 
33342, Trihydrochloride, Trihydrate, Life tech) diluted 1:6000 in 
PBS. Tetramethylrhodamine isothiocyanate-dextran was added to 
the nuclear fraction. The nuclei were mounted with ProLong™ Gold 
Antifade	Mountant	(Invitrogen)	on	cover	slips	and	imaged	with	the	
confocal	microscope	Leica	TCS	SP5	II.
4.14  |  Western Blot (WB) Analysis
iNPC-A samples were lysed using lysis buffer (150 mM NaCl, 
50 mM HEPES, 1 mM EDTA, 1 mM DTT, 0.5% (v/v) Triton™ X-100, 
PIC,	 pH	 8.0).	 Samples	were	 then	 centrifuged	 at	 13,300	 rpm	 for	
5 min at 4°C, and the supernatant was collected. Lysates were 
subjected to sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) on 12% polyacrylamide gels. Resolved pro-
teins were transferred to nitrocellulose membranes and processed 
for immunoblot analysis.
Membranes were blocked for 1 h in 5% milk/tris-buffered saline 
and Tween-20 (TBS-T). Primary antibodies (Table S6) were diluted 
in 5% milk/TBS-T and incubated with the membrane overnight at 
4°C. After primary antibody incubation, the membrane was washed 
for	3	×	5	min	each	 in	TBS-T	buffer.	Secondary	horseradish	perox-
idase (HRP) antibodies (Table S7) were diluted in 5% milk/TBS-T 
and incubated with the membrane for 1 h at room temperature. 
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After secondary antibody incubation, the membrane was washed 
for	3	×	5	min	each	 in	TBS-T	buffer.	Protein	bands	were	visualised	
using EZ-ECL reagent (Geneflow) and the G-Box imaging system 
(Syngene). Densitometric analysis of protein bands was carried out 
using GeneTools Software (Syngene).
4.15  |  Image and statistical analysis
Columbus Software was used in the image analysis setting to meas-
ure different parameters including nuclei numbers, nuclear size (μm2) 
(mean	per	well),	CellROX	intensity/Cell	area,	Lamin	A/C	as	nuclear	
roundness	(arbitrary	units	=	AU)	and	H3K9me3	intensity	(arbitrary	
fluorescent	units	=	AFU).
To investigate differences in nuclear envelope morphology, 
iNPC-As	nuclei	were	first	detected	using	DAPI	with	boundary	ob-
jects removed. The nuclear envelope was detected by expression 
of Lamin A/C restricted to the perinuclear space. This enabled as-
sessment of blebs or irregularities that expand within the nuclear 
DAPI	signal,	which	correlated	with	a	decrease	 in	nuclear	envelope	
roundness. Data were visualised as individual cell nuclear envelope 
roundness using a violin plot with an upper limit of 0.3, which was 
greater than the 95% percentile for both groups.
To	 investigate	whether	 the	 IL-1β interferes with the transloca-
tion of NF-κB, young and old astrocytes were stained for NF-κB, un-
treated cells were used as a control for each line. Reactive gliosis 
was	determined	by	GFAP	and	Vim	staining	 intensity	 (AFU),	which	
was quantified using Harmony software (Perkin Elmer). After the 
treatment the cells were fixed and stained for NF-κB and vimentin 
was	used	as	a	marker	that	defines	the	boundary	of	cells	and	DAPI	
for nuclear staining. Quantitative image analysis of the astrocytes 
was	conducted	through	the	Opera	Phenix™	High	Content	Screening	
System	at	40×	magnification	using	 the	Columbus™	 Image	analysis	
system. The following morphological features were assessed for 
both treated and control astrocytes: cell area and the intensity of 
GFAP and vimentin staining per cell. At least 20 fields were ran-
domly selected and scanned per well of a 96-well plate in triplicate. 
To identify and remove any false readings generated by the sys-
tem, three random treated and untreated wells were selected and 
counted manually (blind to group).
All experiments were performed at least in triplicate (i.e., three 
independent experimental repeats from three different iNPC-A dif-
ferentiation rounds) with a minimum of three technical repeats in 
each independent experiment. Data were analysed using GraphPad 
Prism	 Software	 (V7.02):	 one-way	 ANOVA	 with	 Tukey's	 multiple	
comparisons	 post-test	 or	 two-way	 ANOVA	 with	 Tukey's	 multiple	
comparisons post-test. Two-tailed t test was used to compare old 
donor samples to the young donor samples for qPCR and Western 
blot.
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